Zhejiang Hisun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 27.6% in First Quarter of 2022

Zhejiang Hisun Pharmaceutical Co.,Ltd. (浙江海正药业股份有限公司) (600267.SH) reported a net profit of 136 million yuan in the first quarter of 2022, down 27.6% year-on-year.

Meanwhile, the company posted 3 billion yuan in revenue, down 3% year-on-year.

At the end of the reporting period, it had 19.5 billion yuan in total assets and 12 billion yuan in total liabilities, with a liability-to-asset ratio of 61.5%.